Covid-19 vaccines: the contracts, prices and profits
Aug 11, 2021
2 minutes
Two US companies, Pfizer and Moderna, have raised the prices of their Covid-19 vaccines after data from clinical trials showed their mRNA formula was more effective than cheaper vaccines from Britain’s AstraZeneca and the American drugs maker Johnson & Johnson.
AstraZeneca and Johnson & Johnson have pledged to provide their doses on a not-for-profit basis until the pandemic ends.
Pfizer/BioNTech
Sales worth $11.3bn (£8bn) in the
You’re reading a preview, subscribe to read more.
Start your free 30 days